Profile
| Metric | Value |
|---|---|
| Full Name | Akebia Therapeutics, Inc. |
| Ticker | NASDAQ: AKBA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | akebia.com |
| Employees | 181 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $1.39 | |
| Price, 1D Change | +0.72% | |
| $369M | ||
| - | ||
| - | ||
| 1.00 | ||
| $160M | ||
| Revenue, 1Y Change | -17.70% | |
| -$0.33 | ||
| EPS, 1Y Change | -18.77% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.33 | ||
| EPS Estimate | $0.04 | |
| EPS Est. Change | +112.16% | |
| $160.18M | ||
| Revenue Estimate | $239.35M | |
| Revenue Est. Change | +49.42% | |
| Current Price | $1.39 | |
| Price Target | - | $5.00 |
| Price Tgt. Change | - | +259.71% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.32 | -$0.28 | +13.44% | |
| -$0.26 | -$0.33 | -26.54% | |
| $0.04 | N/A | +112.16% | |
| $0.17 | N/A | +151.67% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $193.88M | $194.62M | +0.38% | |
| $151.05M | $160.18M | +6.05% | |
| $239.35M | N/A | +49.42% | |
| $290.97M | N/A | +81.65% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $1.39 | |
| $2.63 | ||
| SMA 200 vs Price | +88.90% | |
| $1.52 | ||
| SMA 50 vs Price | +9.14% | |
| 1.00 | ||
| $0.08 | ||
| 43.49 | ||
| 52.60% | ||
| 84.00% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $160.18M | ||
| -$0.33 | ||
| $91.34M | ||
| 57.03% | ||
| -$50.41M | ||
| -31.47% | ||
| -$69.41M | ||
| -43.33% | ||
| -$8.71M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -3.96 | ||
| 1.41 | ||
| 1.21 | ||
| - | ||
| 5 | ||
| -9.68 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 1.64 | ||
| 8.87 | ||
| 12.84 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$49.19M | ||
| $51.87M | ||
| $220.67M | ||
| $113.83M | ||
| $269.86M | ||
| $80.91M | ||
| $194.65M | ||
| $15.64M | ||
| $15.18M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $229.59M | ||
| $141.76M | ||
| $68.84M | ||
| $0.00 | ||
| $41.70M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$40.66M | ||
| -$33.00K | ||
| $49.66M | ||
| $33.00K | ||
| -$40.69M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| Leerink Partners | ||
| HC Wainwright & Co. | → | |
| Jefferies | ||
| Piper Sandler | → |
Analyst sentiment
Institutional ownership
Screeners with AKBA
FAQ
What is the ticker symbol for Akebia Therapeutics, Inc.?
The ticker symbol for Akebia Therapeutics, Inc. is NASDAQ:AKBA
Does Akebia Therapeutics, Inc. pay dividends?
No, Akebia Therapeutics, Inc. does not pay dividends
What sector is Akebia Therapeutics, Inc. in?
Akebia Therapeutics, Inc. is in the Healthcare sector
What industry is Akebia Therapeutics, Inc. in?
Akebia Therapeutics, Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Akebia Therapeutics, Inc. based in?
Akebia Therapeutics, Inc. is headquartered in United States
When did Akebia Therapeutics, Inc. go public?
Akebia Therapeutics, Inc. initial public offering (IPO) was on March 20, 2014
Is Akebia Therapeutics, Inc. in the S&P 500?
No, Akebia Therapeutics, Inc. is not included in the S&P 500 index
Is Akebia Therapeutics, Inc. in the NASDAQ 100?
No, Akebia Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Akebia Therapeutics, Inc. in the Dow Jones?
No, Akebia Therapeutics, Inc. is not included in the Dow Jones index
When was Akebia Therapeutics, Inc. last earnings report?
Akebia Therapeutics, Inc.'s most recent earnings report was on November 10, 2025
When does Akebia Therapeutics, Inc. report earnings?
The next expected earnings date for Akebia Therapeutics, Inc. is March 12, 2026
Data Sources & References
- AKBA Official Website www.akebia.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1517022/000151702225000046/0001517022-25-000046-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1517022/000162828025012470/0001628280-25-012470-index.htm
- AKBA Profile on Yahoo Finance finance.yahoo.com/quote/AKBA
- AKBA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/akba